Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The reason to sell now would be to reap the capital loss; the pittance received would be negligible. The potential reward could be immense.
The level of remorse and embarrassment for selling at the bottom is unacceptable. That this was other than speculation from the beginning is fantasy.
Even at the current price, I would be a buyer if I were an 'expert'.
gh
Another IPIX board has had over 4000 views today and no posts since 4-19-2024!
I hope they're all long and strong holders who will not settle for peanuts.
Leo should don a pith helmet and play Albert Schweitzer; offer Brilacicin to a poverty-stricken third-world country. Save millions from blindness and win a Nobel Prize.
gh
It appears now that IPIX is at a critical point of decision, Leo is in charge and it is within his power to step up and save the company from the error of failing to pay the lease that he agreed to. He should pay the $X amount to settle the judgment to close the matter. This would end the immediate threat to the company so we could hold on till our ship comes in. We still own Brilacidin and the stake in BeaMed; either or both of which coulld provide relief down the road. The company has been generous to Leo; now is the time for him to put a little money to save his baby.
If we ascribe financial self-interest to our CEO, and he was to see the sub-penny price range as an opportunity to massively increase his equity position (as many here have), when would his purchases become evident in the required financial disclosure documents?
Conversely, the lack of such purchases might be a warning that he may lack confidence in the value that I and others here have shown by recent purchases. I hope he has been a buyer of late.
gh
As a long-time holder of IPIX shares, I continue to have confidence in Leo Erlich. He holds a significant equity position and a voting position that, as CEO, gives him virtual control of this company. He can maintain control because he knows that DEBT is how he might lose control (See PolyMedix a decade ago). Dilution of the stock value over the years has been both painful and an opportunity for greatness.
I'm 76 years old; I hope I live to see that greatness. I want to read some of the books that will be written about the maze of events that CTIX and IPIX have navigated under Leo's guidance.
Here's hoping that we have seen the low, but if not, hang in there.
Happy New Year!
gh
If someone owned 100,000 shares of IPIX, what fraction of BeaMed would that be?
gh
If and when IPIX achieves its destiny, that few thousand shares will be vastly more valuable.
gh
In fact, I think I'll buy a few thousand more shares this week!
gh
I am a retail investor, buying originally @ $1.00 over a decade ago when Kevetrin was written up in the NY Times. I followed CTIX on the other board daily but only posted there or here infrequently. Checking over there today IPIX shows 1930 board views today(!), and the last post there was Oct. 7th; there are a lot of people interested in our company. The price is so low that I have accumulated over 300,000 shares with an average cost of $.17. Why would I ever consider selling? I'm still an occasional buyer with high hopes for vindication. At 76 years of age, I hope that happens in my lifetime. If not I'll leave a note for my heirs to hang on, unless they are destitute.
gh
IPIX will not go bankrupt till it owes money it can't pay, Leo has done a great job maneuvering IPIX for the possibility of success. It would help if he would take a pay cut.
gh
JT, you totally miss the point. If BeaMed is a roaring success, even if IPIX drugs are a bust, our stock could skyrocket based on the value of our holding in BeaMed alone. With that value realized the cash for drug validation may prove to be MIRACULOUS, in more ways than one.
gh
It seems plausible; Buying IPIX stock is a way to own a piece of BeaMed. I'm happy with my piece (and may buy more).
gh
Thank you Frenchy for all your ongoing efforts to remind us longs why we are here and to inform any newcomers of our extraordinary opportunity!
gh
It seems odd, but I try to think of the price as irrelevant. Except that when it dips, sometimes I cannot resist buying a few 10,000 shares in full belief that their value will sooner or later be recognized by all.
gh
Why would any true long-term holder of IPIX sell now?
gh
The link is an Instagram post. The same story is here:
https://cbs12.com/news/local/brevard-county-gop-covid-19-vaccine-bioweapon-gov-ron-desantis-florida-attorney-general-ashley-moody-treasure-coast-july-13-2023
I hear the Saudis and other Mideasterners have lots of money.
gh
When Brilacidin comes into its rightful valuation, Leo Ehrlich will be held in high esteem. There will be books written about the circuitous route he led IPIX through to its eventual success and rightful place in medical history. I hope I live long enough to be vindicated.
gh
At worst, IPIX is a $.018 lottery ticket. Why would anyone sell? I've said it before, "Brilacidin is the Penicillin of the 21st Century." I hope this septuagenarian lives long enough to read some of the books that will be written about this wonder drug.
gh
I agree, AlphaSigma has shown nothing so far. Is there any reason to say that it will not have financial benefit to IPIX going forward?
gh
There is an outbreak of Dengue fever in Peru. Has brilacidin been tested in vitro or in vivo against Dengue? Does Peru have a flexible enough corollary of the FDA to allow for emergency approval?
gh
Rahway, N.J. is a suburban town near NYC. It is the headquarters of Merck and Company.
gh
Does anyone have an opinion about the Brazillian counterpart of the FDA; would we have less 'difficulty' emerging successfully there?
gh
Virtually nobody is selling. Why would one sell for such a pittance? Volume today as of 3:54 is 85557 shares. The lower it goes, the more I am inclined to buy.
gh
It depends on what you mean by "worth."
gh
Price up 20% with no news! Does anyone know anything?
gh
Les go to Brazil for approval of Brilacidin to treat fungal infections. Sidestep the corrupt FDA.
gh
A reverse merger with BeaMed would solidify our position in laser surgery and with the dynamic leadership of that company, the realization of the value of Brilacidin would get a new set of investors eyes to power us forward.
gh
At this point, the price could double or more on the slightest real positive news. Why would any long-suffering holder sell now?
gh
Maybe with Dr. Goldman on board, Brilacidin could get approval in Brazil; escaping the tentacles of the FDA. Or Japan, Egypt, India, or any of dozens of other countries that have the health of their people as a priority.
gh
It is amazing that anyone would sell at this ridiculously low price.
Thanks especially to Frenchbroad for all your due diligence!
gh
Thanks for confirming my recollection. This obliterates the hypertension canard!
gh
Someone, please correct me if my 75-year-old brain is misremembering info about the hypertension problem with B. I think that arose in an early trial ( by Poly Medics?). The dosage of B was seriously reduced and the hypertension was avoided but the efficacy remained.
gh
That is only an opinion. You cannot Know this.
gh
I am a longtime holder of IPIX and continue to hope for the best. The new LASER surgery investment might be the key to giving us the funding for progress with Brilacidin (and Kevetrin?).
For several years I've had hopes for Brilacidin's approval in some foreign country that could circumvent the big pharma stranglehold over the FDA that we suffer with in the USA.
May we all have a Happy and Prosperous New Year!
gh
I too have been here for many years (a decade) and look upon IPIX as an important part of my life. For a few years, while CTIX was ascendant, I was vocal about its prospects; several friends lost money to my embarrassment and chagrin. I no longer brag about my investing prowess.
The purchase in bankruptcy of Brilacidin's former owner was a big surprise. The lesson of Polymedix is not to go into debt that can be fatal to a company if revenue expectations disappoint. I believe that Leo has learned this lesson. Dilution is acceptable; bankruptcy is not.
The science of Brilacidin is what I have faith in. I've posted many times my opinion that Brilacidin is the penicillin of the 21st Century. I'm 75 years of age. I would rather die with my many(and increasing) shares of IPIX than sell for a pittance. I will instruct my heirs to NEVER sell before the vindication of Brilacidin's potential in the marketplace!
Merry Christmas and Happy (and Prosperous) New Year
I bought CTIX in 2012 for $1.00 because I saw a NY Times article about the Kevetrin cancer trial at Harvard's Brigham and Women's Hospital. I was a genius for a while. I have added over the years and will never sell at a loss. I'm 75 now and hope to see the vindication of both Kevetrin and Brilacidin. I've posted several times that Brilacidin is the Penicillin of the 21st Century. There will be books written about the shenanigans that we holders have endured when approval is granted.
Good luck to all holders of IPIX. Happy Thanksgiving to all!
gh
Correct me if I'm wrong, but the only way for an investor to invest a few thousand dollars in BeaMed would be to buy IPIX shares.
I like this turn of events.
gh
It is better to live with controlled dilution than to die in bankruptcy due to unpaid debt.
gh